GMED
NYSE
US
Globus Medical, Inc. Class A Common Stock
$94,44
▲ +$1,68
(+1,81%)
Vol. 21K
Cap. mercato
$12.8B
P/E
23,7
ROE
12,4%
Margine
18,3%
Beta
1,06
52W
$52–$101
Consenso Wall Street
22 analisti · Apr 20264
Acquisto forte
12
Compra
6
Mantieni
0
Vendi
0
Vendita forte
72,7%
Rating Compra
Grafico dei Prezzi
Titoli simili
DXCM
Dexcom Inc
P/E 35,9
$25.9B
ZBH
Zimmer Biomet Holdings, Inc
P/E 26,7
$18.8B
PODD
Insulet Corp
P/E 81,2
$20.0B
PEN
Penumbra Inc
P/E 73,4
$13.0B
MASI
Masimo Corp
$7.0B
BAX
Baxter International Inc
$9.3B
GKOS
Glaukos Corp
$7.1B
TFX
Teleflex Inc
$5.7B
NVST
Envista Holdings Corp
P/E 93,9
$4.4B
ABT
Abbott Laboratories
P/E 26,3
$165.2B
Utili
Tasso di battuta: 75,0%
Prossimo report
Mag 12, 2026
Stima EPS: $0,94
| Trimestre | EPS Stimato | EPS Effettivo | Sorpresa |
|---|---|---|---|
| Mar 2026 | $0,94 | — | — |
| Dic 2025 | $1,17 | $1,28 | +$0,11 |
| Set 2025 | $0,80 | $1,18 | +$0,38 |
| Giu 2025 | $0,77 | $0,86 | +$0,09 |
Ricavi e utili trimestrali
| Trimestre | 2024-0… | 2024-1… | 2025-0… | 2025-0… | 2025-0… | 2025-1… |
|---|---|---|---|---|---|---|
| Ricavi | — | $657.3M | $598.1M | $745.3M | $769.0M | $826.4M |
| Utile netto | — | $26.5M | $75.5M | $202.8M | $119.0M | $140.6M |
Trend fondamentali
| Metrica | 2026-04-12 | 2026-04-17 |
|---|---|---|
| ROE (TTM) | 12.4% | 12.4% |
| P/E (TTM) | 22.70 | 23.74 |
| Net Margin | 18.3% | 18.3% |
| Gross Margin | 67.4% | 67.4% |
| D/E Ratio | — | — |
| Current Ratio | 4.26 | 4.26 |
Rapporti chiave
ROA (TTM)
10,7%
P/S (TTM)
4,34
P/B
2,6
EPS (TTM)
$3,93
CF/Share
$2,36
Crescita ricavi 3A
+42,2%
52W High
$101,40
52W Low
$51,79
$51,79
Intervallo 52 settimane
$101,40
Salute finanziaria
Flusso di cassa libero
$202.3M
Debito netto
-$407.5M
Liquidità
$526.2M
Debito totale
$118.7M
Aggiornato al Dic 31, 2025
Як GMED виглядає на тлі конкурентів у Health Care?
Група порівняння: Peers · Health Care (Peers) · 10 компаній
Оцінка GMED vs аналоги Health Care
P/E
22,7
▼
14%
sotto
peer
(26,3)
vs Peer
vs Settore
Sottovalutato
P/S
4,2
▼
16%
sotto
peer
(4,9)
vs Peer
vs Settore
Più costoso
P/B
2,6
▼
51%
sotto
peer
(5,3)
vs Peer
vs Settore
Sottovalutato
Дивідендна дохідність
—
▼
0%
sotto
peer
(1,1%)
vs Peer
vs Settore
In linea
Прибутковість GMED vs аналоги Health Care
ROE
12,4%
▼
22%
sotto
peer
(15,9%)
vs Peer
vs Settore
Debole
Net margin
18,3%
▲
34%
sopra
peer
(13,7%)
vs Peer
vs Settore
Top livello
Валова маржа
67,4%
▲
10%
sopra
peer
(61,3%)
vs Peer
vs Settore
Top livello
ROA
10,7%
▲
19%
sopra
peer
(9,0%)
vs Peer
vs Settore
Top livello
Фінансове здоровʼя GMED vs аналоги Health Care
D/E ratio
—
▼
0%
sotto
peer
(82,5)
vs Peer
vs Settore
In linea
Поточна ліквідність
4,3
▲
140%
sopra
peer
(1,8)
vs Peer
vs Settore
Liquidità forte
Beta
1,1
▲
5%
sopra
peer
(1,0)
vs Peer
vs Settore
Meno volatile
Радар фундаменталів GMED
GMED
Mediana peer
Industria
GMED прибутковість vs борг
Розмір бульбашки = капіталізація · X = чиста маржа · Y = D/E ratio
GMED vs аналоги: ключові метрики
Attività insider
BearishAcquisti
0
Vendite
2
$2766700
HULLER KELLY GRACE
General Counsel · Feb 25
sale
20000 shs
HULLER KELLY GRACE
General Counsel · Feb 25
conversion of exercise of derivative security
20000 shs
HULLER KELLY GRACE
General Counsel · Feb 12
sale
10000 shs
HULLER KELLY GRACE
General Counsel · Feb 12
conversion of exercise of derivative security
10000 shs
Ultimo 90 giorni
Principali azionisti
Top 5: 26,22%Vanguard Group Inc
7,80%
$953.9M
Blackrock Inc.
7,60%
$929.9M
Janus Henderson Group PLC
5,39%
$659.6M
Invesco Ltd.
2,87%
$351.4M
State Street Corporation
2,56%
$313.2M
Aggiornato al Dic 31, 2025